In this unique one-hour webinar, Dr. Jena outlines a broader framework for assessing value to improve identification of not only the highest-value treatments, but also low-value therapies on which spending can safely be reduced.
We are pleased to announce that Precision’s Chief Scientist Dr. Jeroen Jansen will be participating in a special workshop organized by ISPOR on the topic of value assessments. The workshop, part of ISPOR’s ongoing Summit Series, will take place on Thursday, February 28th, 2019 at 12:00pm EST. Entitled Novel Approaches to Value Assessment, WITHIN the Cost-Effectiveness Framework, this webinar will feature a video presentation from Dr. Jansen as well as a live Q&A session at the conclusion with moderator Lou Garrison, PhD.
Senior Research Economist James Baumgardner will be presenting “CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments” at the American Society of Hematology (ASH) 60thAnnual Meeting and Exposition, taking place from December 1-4 in San Diego, CA.
Lessons Learned from the Oncology Care Model Implementation: Maximizing the Value of Health Economics Evidence—presented by PHE Senior Economist and former Congressional Budget Office Deputy Assistant Director, Dr. James Baumgardner, and PHE Scientific Advisor, Dr. Wade Aubry, former Chief Medical Officer of Blue Shield of California. […]
The ISPOR 23rd Annual International Meeting took place in Baltimore, Maryland from May 19-23, and Precision Health Economics (PHE) and Precision Xtract were both there to meet with you and share our expertise. […]
For more information, or to learn how to change your cookies preferences, please click here.